Parkinson’s Institute and Clinical Center Company Profile

01:59 EDT 23rd October 2018 | BioPortfolio

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care, basic science research, and clinical research in one integrated model. Our unique freestanding organization directly connects research to patient care – from the “bench to bedside.” For 30 years, our team of epidemiologists, physicians, scientists, and therapists, have been at the forefront of every clinical and scientific discovery in the field of Parkinson’s research.

News Articles [2787 Associated News Articles listed on BioPortfolio]

Parkinson’s Institute and Clinical Center and Retrotope Announce Collaboration on New Drug Treatment Therapies for Parkinson’s Disease Patients

SUNNYVALE and LOS ALTOS, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Parkinson’s Institute and Clinical Center, which provides comprehensive patient care, while discovering new treatment options to...

First-ever qualified Parkinson's biomarker is vital step toward improved clinical trials

(Critical Path Institute (C-Path)) The Critical Path Institute's (C-Path) Critical Path for Parkinson's Consortium (CPP), in partnership with Parkinson's UK, announces that the European Medicines Agen...

Huntsman Cancer Institute opens Center for HOPE

(Huntsman Cancer Institute) Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and...

Link between tuberculosis and Parkinson's disease discovered

(The Francis Crick Institute) The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson's disease, according to a new study. The fin...

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and...

Tufts CTSI receives $56 Million NIH Clinical and Translational Science Award

(Tufts Clinical and Translational Science Institute) Tufts University and Tufts Medical Center today announced that the National Institutes of Health's National Center for Advancing Translational Scie...

The Michael J. Fox Foundation Launches Parkinson’s Clinical Trial Platform

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched an educational suite dubbed the “Parkinson’s Clinical Trial Companion.”

Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Announce Collaboration to Target Gastrointestinal Metabolites That May Contribute to Parkinson’s Disease

Parkinson’s Institute and Clinical Center (PICC) and Axial Biotherapeutics announced today a collaboration to investigate interventions targeting gastrointestinal (GI) metabolit...

Drugs and Medications [402 Associated Drugs and Medications listed on BioPortfolio]

Exelon [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Exelon  Patch safely and effectively. See full prescribing information for Exelon Patch.       Exelon  Patch (rivastig

Aprodine [Rebel Distributors Corp]


Premier value chest congestion and cough releif [Reese Pharmaceutical Co]

drug facts

Care one chest congestion relief [Reese Pharmaceutical Co]

drug facts

Cvs chest congestion relief [Reese Pharmaceutical Co]

Drug Facts CVS Congestion Relief DM

PubMed Articles [3451 Associated PubMed Articles listed on BioPortfolio]

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease. These criteria aimed to codify/reproduce the expert clinical diagnost...

Diabetes mellitus and Parkinson disease.

To investigate whether diabetes mellitus is associated with Parkinson-like pathology in people without Parkinson disease and to evaluate the effect of diabetes mellitus on markers of Parkinson patholo...

Center of pressure-based balance evaluation in individuals with Parkinson's disease: a reliability study.

The purpose of this study was to assess the test-retest reliability of different balance task outcomes, based on center of pressure (COP) measures in individuals with Parkinson's disease.

PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.

Parkinson's disease (PD) shares pathological and clinical features with progressive supranuclear palsy (PSP) patients making the diagnosis challenging. Distinguishing PD from PSP is crucial given diff...

Pimavanserin use in a movement disorders clinic: a single-center experience.

Parkinson's disease psychosis (PDP) is a disabling non-motor symptom of Parkinson's disease (PD) that is challenging to treat. Dopamine receptor blockers (DRB) are used to treat PDP, though these may ...

Clinical Trials [5497 Associated Clinical Trials listed on BioPortfolio]

The Clinical Profile of Parkinson Disease in Egypt

Multi-center, retrospective observational cohort study in 4 tertiary referral centers in Cairo over the period from 2004 to 2016. Study population. including all patients with idiopathic ...

Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo ...

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC)...

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Study participants who have been clinically diagnosed with Parkinson disease will receive no treatment, treatment with either levodopa, or treatment with Mirapex for a period of 12 weeks. ...

Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study

The purpose of this study is to examine the role of genetic and environmental factors in the cause of Parkinson's disease.

Companies [4175 Associated Companies listed on BioPortfolio]

Parkinson’s Institute and Clinical Center

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care,...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death,...

Burnham Institute

The Burnham Institute is an independent, nonprofit, public benefit organization dedicated to basic biomedical research. Founded in 1976, the Institute was originally known as La Jolla Cancer Research ...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

Miami Cancer Institute

Miami Cancer Institute offers comprehensive cancer services and is expanding its clinical services, clinical trials and state-of-the-art technology, including offering the first p...

More Information about "Parkinson’s Institute and Clinical Center" on BioPortfolio

We have published hundreds of Parkinson’s Institute and Clinical Center news stories on BioPortfolio along with dozens of Parkinson’s Institute and Clinical Center Clinical Trials and PubMed Articles about Parkinson’s Institute and Clinical Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Parkinson’s Institute and Clinical Center Companies in our database. You can also find out about relevant Parkinson’s Institute and Clinical Center Drugs and Medications on this site too.

Quick Search


Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Corporate Database Quicklinks

Searches Linking to this Company Record